UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000009486 |
|---|---|
| Receipt number | R000010583 |
| Scientific Title | Cerebral blood flow in hypothyroidism: ASL(Arterial Spin Labeling) study |
| Date of disclosure of the study information | 2012/12/05 |
| Last modified on | 2015/07/12 21:18:54 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Cerebral blood flow in hypothyroidism: ASL(Arterial Spin Labeling) study
Acronym
CBF in hypothyroidism
Scientific Title
Cerebral blood flow in hypothyroidism: ASL(Arterial Spin Labeling) study
Scientific Title:Acronym
CBF in hypothyroidism
Region
| Japan |
Condition
Condition
transient hypothyroidism in induced by post-thyroidectomy
Classification by specialty
| Endocrinology and Metabolism | Radiology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To investigate of alterations in regional cerebral blood flow(rCBF) distribution in patients with transient hypothyroidism after thyroidectomy and before I-131 therapy. .
Basic objectives2
Others
Basic objectives -Others
We compare differences in regional rCBF of the patients and control groups. In addition, the effects of thyroxine treatment on rCBF changes are studied.
Trial characteristics_1
Exploratory
Trial characteristics_2
Explanatory
Developmental phase
Not applicable
Assessment
Primary outcomes
A comparison of rCBF of the patients and control groups.
Key secondary outcomes
1. The effects of thyroxine treatment on rCBF changes
2. The association between Hamilton Rating Scale for Depression(HAMD)/Beck Depression Index(BDI) and rCBF.
3. The association between FT3/FT4 and rCBF.
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients:1.After thyroidectomy and before I-131 therapy. 2. People twenty years old and over at the time of the consent. 3. People who see a doctor regularly in Hiroshima University Hospital after I-131 therapy. 4. People who can consent to this study in writing.
Control: 1. People who don't have any metal disorders. 2. People who don't have thyroidal disorders. 3. People who don't have any other seriously ill. 4. People who can consent to this study in writing.
Key exclusion criteria
1. Contraindication to MRI(cardiac pacemaker; cochlear implantation device; defibrillator; neurostimulator; bone growth stimulation device; infusion pump; deep brain stimulation; cervical artery crump(Poppen-Blaylock); chip of ferromagnetic substance in eyeball, brain, internal organs, lung, mediastinum; intraaortic filter, intravascular coil or stent within 2 months)
2. People who were unsuitable for this study.
Target sample size
70
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Kazuo Awai |
Organization
Institute of Biomedical and Health Sciences, Hiroshima University
Division name
Diagnostic Radiology
Zip code
Address
Kasumi 1-2-3, Minami-ku, Hiroshima
TEL
082-257-5257
awai@hiroshima-u.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Yoko Kaichi |
Organization
Graduate School of Biomedical and Health Sciences, Hiroshima University
Division name
Diagnostic Radiology
Zip code
Address
Kasumi 1-2-3, Minami-ku, Hiroshima
TEL
082-257-5257
Homepage URL
kaichi@hiroshima-u.ac.jp
Sponsor or person
Institute
Institute of Biomedical and Health Sciences, Hiroshima University
Institute
Department
Personal name
Funding Source
Organization
none.
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
広島大学病院（広島県）
Other administrative information
Date of disclosure of the study information
| 2012 | Year | 12 | Month | 05 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2012 | Year | 08 | Month | 17 | Day |
Date of IRB
Anticipated trial start date
| 2012 | Year | 11 | Month | 01 | Day |
Last follow-up date
| 2014 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
| 2014 | Year | 12 | Month | 31 | Day |
Date trial data considered complete
| 2014 | Year | 12 | Month | 31 | Day |
Date analysis concluded
| 2015 | Year | 09 | Month | 30 | Day |
Other
Other related information
prospective study
Management information
Registered date
| 2012 | Year | 12 | Month | 05 | Day |
Last modified on
| 2015 | Year | 07 | Month | 12 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010583
| Research Plan | |
|---|---|
| Registered date | File name |
| Research case data specifications | |
|---|---|
| Registered date | File name |
| Research case data | |
|---|---|
| Registered date | File name |
